Screener
NewAmsterdam Pharma Company NAMS Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $3.96B.
The source filing: NewAmsterdam Pharma Company’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333824
FAQ
- What is NewAmsterdam Pharma Company's market capitalization?
- NewAmsterdam Pharma Company (NAMS) reported market capitalization of $3.96B in Q2 2026.
- How has NewAmsterdam Pharma Company's market capitalization changed year-over-year?
- NewAmsterdam Pharma Company's market capitalization increased by 91.8% year-over-year, from $2.07B to $3.96B.
- What is the long-term trend for NewAmsterdam Pharma Company's market capitalization?
- Over 4 years (2021 to 2025), NewAmsterdam Pharma Company's market capitalization has grown at a 45.9% compound annual growth rate (CAGR), from $877.36M to $3.98B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about NewAmsterdam Pharma Company's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude